New 'Smart Bomb' drug seeks to target advanced cancers
Disease control
Recruiting now
This is an early-stage study to find a safe dose and check the side effects of a new experimental drug called OBT076. The drug is designed to target and kill cancer cells that have a specific marker (CD205) and have stopped responding to standard treatments. The study will enroll…
Phase: PHASE1 • Sponsor: Oxford BioTherapeutics Ltd • Aim: Disease control
Last updated Mar 02, 2026 15:29 UTC